Coronavirus COVID19
Publications
Journals
India in Cognitive Dissonance
Support GGI
Search
Friday, June 9, 2023
Publications
Journals
India in Cognitive Dissonance
Events
Host GGI Lectures
Join Us
Press Release
हिंदी
GreatGameIndia
Coronavirus COVID19
Publications
Journals
India in Cognitive Dissonance
Support GGI
Tag: Eli Lilly and Co.
Eli Lilly Obesity Drug Poised To Blow Up Weight Loss Industry
GGI Staff
-
May 7, 2023
0
Tirzepatide, an Eli Lilly and Co. obesity drug approved to treat type 2 diabetes, is poised to blow up the weight loss industry.
Read more
Edit with Live CSS